Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001599901-25-000119
Filing Date
2025-06-12
Accepted
2025-06-12 18:26:06
Documents
1
Period of Report
2025-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749767160.html 4  
1 FORM 4 wk-form4_1749767160.xml 4 5746
  Complete submission text file 0001599901-25-000119.txt   7447
Mailing Address C/O KURA ONCOLOGY, INC. 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address
WILSON TROY EDWARD (Reporting) CIK: 0001589597 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39321 | Film No.: 251044186

Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Issuer) CIK: 0001599901 (see all company filings)

EIN.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)